| 000 | 01778 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518093250.0 | ||
| 264 | 0 | _c20200911 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1432-0711 | ||
| 024 | 7 |
_a10.1007/s00404-020-05505-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOuyang, Peilin | |
| 245 | 0 | 0 |
_aComparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study. _h[electronic resource] |
| 260 |
_bArchives of gynecology and obstetrics _c05 2020 |
||
| 300 |
_a1247-1255 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aChemoradiotherapy _xmethods |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHysterectomy |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xpathology |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 700 | 1 | _aCai, Jingting | |
| 700 | 1 | _aGui, Lin | |
| 700 | 1 | _aLiu, Shan | |
| 700 | 1 | _aWu, Na-Yi Yuan | |
| 700 | 1 | _aWang, Jing | |
| 773 | 0 |
_tArchives of gynecology and obstetrics _gvol. 301 _gno. 5 _gp. 1247-1255 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00404-020-05505-6 _zAvailable from publisher's website |
| 999 |
_c30789616 _d30789616 |
||